353 related articles for article (PubMed ID: 32683902)
1. Ca
Zhao GJ; Zhao CL; Ouyang S; Deng KQ; Zhu L; Montezano AC; Zhang C; Hu F; Zhu XY; Tian S; Liu X; Ji YX; Zhang P; Zhang XJ; She ZG; Touyz RM; Li H
Hypertension; 2020 Sep; 76(3):827-838. PubMed ID: 32683902
[TBL] [Abstract][Full Text] [Related]
2. NADPH Oxidase 5 Is a Pro-Contractile Nox Isoform and a Point of Cross-Talk for Calcium and Redox Signaling-Implications in Vascular Function.
Montezano AC; De Lucca Camargo L; Persson P; Rios FJ; Harvey AP; Anagnostopoulou A; Palacios R; Gandara ACP; Alves-Lopes R; Neves KB; Dulak-Lis M; Holterman CE; de Oliveira PL; Graham D; Kennedy C; Touyz RM
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907654
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
Montezano AC; Burger D; Paravicini TM; Chignalia AZ; Yusuf H; Almasri M; He Y; Callera GE; He G; Krause KH; Lambeth D; Quinn MT; Touyz RM
Circ Res; 2010 Apr; 106(8):1363-73. PubMed ID: 20339118
[TBL] [Abstract][Full Text] [Related]
4. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
5. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Zhang Q; Tan Y; Zhang N; Yao F
Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
[TBL] [Abstract][Full Text] [Related]
6. NOX5: Molecular biology and pathophysiology.
Touyz RM; Anagnostopoulou A; Rios F; Montezano AC; Camargo LL
Exp Physiol; 2019 May; 104(5):605-616. PubMed ID: 30801870
[TBL] [Abstract][Full Text] [Related]
7. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
[TBL] [Abstract][Full Text] [Related]
8. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
9. Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway.
Papparella I; Ceolotto G; Montemurro D; Antonello M; Garbisa S; Rossi G; Semplicini A
J Nutr; 2008 Sep; 138(9):1596-601. PubMed ID: 18716156
[TBL] [Abstract][Full Text] [Related]
10. Importance of cholesterol-rich microdomains in the regulation of Nox isoforms and redox signaling in human vascular smooth muscle cells.
Anagnostopoulou A; Camargo LL; Rodrigues D; Montezano AC; Touyz RM
Sci Rep; 2020 Oct; 10(1):17818. PubMed ID: 33082354
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.
Palomeque J; Rueda OV; Sapia L; Valverde CA; Salas M; Petroff MV; Mattiazzi A
Circ Res; 2009 Dec; 105(12):1204-12. PubMed ID: 19850941
[TBL] [Abstract][Full Text] [Related]
12. Contractile Function During Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation.
Zhang M; Prosser BL; Bamboye MA; Gondim ANS; Santos CX; Martin D; Ghigo A; Perino A; Brewer AC; Ward CW; Hirsch E; Lederer WJ; Shah AM
J Am Coll Cardiol; 2015 Jul; 66(3):261-272. PubMed ID: 26184620
[TBL] [Abstract][Full Text] [Related]
13. Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension.
Camargo LL; Montezano AC; Hussain M; Wang Y; Zou Z; Rios FJ; Neves KB; Alves-Lopes R; Awan FR; Guzik TJ; Jensen T; Hartley RC; Touyz RM
Cardiovasc Res; 2022 Mar; 118(5):1359-1373. PubMed ID: 34320175
[TBL] [Abstract][Full Text] [Related]
14. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells.
Andueza A; Garde N; García-Garzón A; Ansorena E; López-Zabalza MJ; Iraburu MJ; Zalba G; Martínez-Irujo JJ
Free Radic Biol Med; 2018 Oct; 126():15-26. PubMed ID: 30036633
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
17. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
18. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
20. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.
Byrne JA; Grieve DJ; Bendall JK; Li JM; Gove C; Lambeth JD; Cave AC; Shah AM
Circ Res; 2003 Oct; 93(9):802-5. PubMed ID: 14551238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
